| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Large B-Cell, Diffuse | 4 | 2024 | 143 | 1.610 |
Why?
|
| Lymphoma, T-Cell | 7 | 2021 | 65 | 1.540 |
Why?
|
| Anemia, Aplastic | 2 | 2025 | 60 | 1.470 |
Why?
|
| Translocation, Genetic | 4 | 2024 | 356 | 1.320 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2022 | 292 | 1.310 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2017 | 138 | 0.980 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 127 | 0.980 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2025 | 189 | 0.960 |
Why?
|
| Ethosuximide | 1 | 2025 | 14 | 0.960 |
Why?
|
| Burkitt Lymphoma | 2 | 2024 | 144 | 0.890 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 2 | 2022 | 46 | 0.880 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 173 | 0.850 |
Why?
|
| Biomarkers, Tumor | 6 | 2024 | 1473 | 0.830 |
Why?
|
| Herpesvirus 4, Human | 3 | 2022 | 676 | 0.820 |
Why?
|
| Anticonvulsants | 1 | 2025 | 381 | 0.770 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2023 | 133 | 0.730 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 1709 | 0.680 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 142 | 0.670 |
Why?
|
| Anemia | 1 | 2023 | 340 | 0.660 |
Why?
|
| Flow Cytometry | 3 | 2017 | 804 | 0.650 |
Why?
|
| Tertiary Healthcare | 1 | 2019 | 21 | 0.640 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 197 | 0.620 |
Why?
|
| Hodgkin Disease | 1 | 2021 | 293 | 0.620 |
Why?
|
| Lymphocyte Transfusion | 1 | 2018 | 57 | 0.600 |
Why?
|
| Leukopenia | 2 | 2023 | 44 | 0.590 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 224 | 0.570 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2017 | 20 | 0.560 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2022 | 211 | 0.500 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2015 | 32 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2015 | 65 | 0.470 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 482 | 0.470 |
Why?
|
| Philadelphia Chromosome | 1 | 2014 | 40 | 0.460 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2014 | 41 | 0.460 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 61 | 0.460 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 44 | 0.460 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2017 | 212 | 0.450 |
Why?
|
| Panniculitis | 1 | 2013 | 19 | 0.430 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2022 | 133 | 0.420 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 66 | 0.410 |
Why?
|
| Adolescent | 14 | 2025 | 19339 | 0.410 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 85 | 0.390 |
Why?
|
| Myeloproliferative Disorders | 1 | 2013 | 87 | 0.390 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2015 | 764 | 0.390 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 621 | 0.380 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 2 | 2022 | 20 | 0.380 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2012 | 205 | 0.340 |
Why?
|
| Monocytes | 1 | 2012 | 354 | 0.330 |
Why?
|
| Child | 12 | 2024 | 24476 | 0.320 |
Why?
|
| Humans | 34 | 2025 | 124905 | 0.320 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2008 | 20 | 0.300 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 538 | 0.290 |
Why?
|
| Gene Rearrangement | 2 | 2014 | 321 | 0.280 |
Why?
|
| Bone Marrow | 3 | 2021 | 325 | 0.280 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2008 | 129 | 0.260 |
Why?
|
| Tertiary Care Centers | 2 | 2023 | 237 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 1291 | 0.240 |
Why?
|
| Diagnosis, Differential | 5 | 2024 | 1895 | 0.240 |
Why?
|
| Female | 12 | 2025 | 66624 | 0.240 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2017 | 116 | 0.230 |
Why?
|
| Primary Myelofibrosis | 2 | 2023 | 51 | 0.230 |
Why?
|
| Lymph Nodes | 2 | 2019 | 380 | 0.230 |
Why?
|
| Transcription Factors | 3 | 2022 | 2609 | 0.230 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2016 | 136 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2024 | 78 | 0.220 |
Why?
|
| Reticulocytes | 1 | 2023 | 42 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2024 | 100 | 0.220 |
Why?
|
| Male | 15 | 2023 | 61355 | 0.210 |
Why?
|
| Retrospective Studies | 6 | 2023 | 16309 | 0.200 |
Why?
|
| Hemoglobins | 1 | 2023 | 303 | 0.200 |
Why?
|
| ROC Curve | 1 | 2023 | 570 | 0.190 |
Why?
|
| Cryptococcosis | 1 | 2021 | 42 | 0.190 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 110 | 0.190 |
Why?
|
| Drug Eruptions | 1 | 2021 | 33 | 0.190 |
Why?
|
| Ribs | 1 | 2021 | 45 | 0.190 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 120 | 0.180 |
Why?
|
| Adenine | 1 | 2021 | 101 | 0.180 |
Why?
|
| Ligands | 1 | 2022 | 536 | 0.180 |
Why?
|
| Child, Preschool | 6 | 2019 | 14055 | 0.170 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 251 | 0.170 |
Why?
|
| Down-Regulation | 4 | 2017 | 701 | 0.170 |
Why?
|
| Mediastinal Neoplasms | 1 | 2020 | 40 | 0.170 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 1228 | 0.170 |
Why?
|
| Piperidines | 1 | 2021 | 205 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2021 | 253 | 0.170 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 12 | 0.170 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2020 | 90 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 296 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 158 | 0.160 |
Why?
|
| Testicular Neoplasms | 1 | 2020 | 133 | 0.160 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 145 | 0.160 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2143 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2016 | 1004 | 0.160 |
Why?
|
| Prognosis | 3 | 2019 | 4615 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2021 | 205 | 0.160 |
Why?
|
| Biopsy | 3 | 2021 | 1237 | 0.150 |
Why?
|
| Cell Proliferation | 4 | 2018 | 2307 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1135 | 0.140 |
Why?
|
| Lung Transplantation | 1 | 2021 | 320 | 0.140 |
Why?
|
| Up-Regulation | 3 | 2015 | 867 | 0.140 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2017 | 30 | 0.140 |
Why?
|
| Image-Guided Biopsy | 1 | 2017 | 37 | 0.140 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 24 | 0.130 |
Why?
|
| Megakaryocytes | 1 | 2016 | 43 | 0.130 |
Why?
|
| Syndrome | 1 | 2018 | 1119 | 0.130 |
Why?
|
| Apoptosis | 1 | 2022 | 1792 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2013 | 840 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2017 | 334 | 0.120 |
Why?
|
| Sumoylation | 1 | 2015 | 35 | 0.120 |
Why?
|
| Receptors, Somatomedin | 1 | 2015 | 25 | 0.120 |
Why?
|
| Monosomy | 1 | 2015 | 24 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 1341 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 109 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 227 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2015 | 330 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1691 | 0.110 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 303 | 0.110 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2014 | 24 | 0.110 |
Why?
|
| Cytokines | 2 | 2021 | 1291 | 0.110 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2013 | 15 | 0.110 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 23 | 0.110 |
Why?
|
| Axilla | 1 | 2013 | 38 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2092 | 0.110 |
Why?
|
| Genomics | 1 | 2021 | 1494 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 356 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 1608 | 0.100 |
Why?
|
| Leukemia | 1 | 2016 | 370 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 96 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2013 | 356 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2043 | 0.100 |
Why?
|
| Liver | 1 | 2019 | 1765 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 139 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 284 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 618 | 0.090 |
Why?
|
| Infant | 4 | 2019 | 12488 | 0.090 |
Why?
|
| Recurrence | 1 | 2015 | 1427 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 222 | 0.090 |
Why?
|
| Prevalence | 1 | 2017 | 2451 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 540 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5158 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 3151 | 0.080 |
Why?
|
| Cell Survival | 3 | 2017 | 807 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 333 | 0.080 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2008 | 33 | 0.070 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2008 | 63 | 0.070 |
Why?
|
| Age Factors | 1 | 2014 | 2821 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 3342 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2013 | 862 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2016 | 1900 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2015 | 12354 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 530 | 0.060 |
Why?
|
| Phenotype | 1 | 2015 | 4260 | 0.060 |
Why?
|
| Time Factors | 1 | 2015 | 6313 | 0.060 |
Why?
|
| Young Adult | 2 | 2017 | 9000 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 577 | 0.050 |
Why?
|
| Mice | 5 | 2021 | 17749 | 0.050 |
Why?
|
| Neoplasms | 1 | 2017 | 2788 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2017 | 1626 | 0.050 |
Why?
|
| Mutation | 3 | 2021 | 5814 | 0.050 |
Why?
|
| Perforin | 1 | 2021 | 17 | 0.050 |
Why?
|
| Middle Aged | 3 | 2021 | 26756 | 0.050 |
Why?
|
| Acute Disease | 1 | 2024 | 1109 | 0.040 |
Why?
|
| Cell Movement | 2 | 2015 | 834 | 0.040 |
Why?
|
| Cytogenetic Analysis | 1 | 2020 | 79 | 0.040 |
Why?
|
| Algorithms | 2 | 2021 | 1618 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 195 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 183 | 0.040 |
Why?
|
| Animals | 5 | 2021 | 34207 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 267 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2021 | 289 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 324 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2017 | 4543 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2022 | 820 | 0.040 |
Why?
|
| Nerve Growth Factor | 1 | 2017 | 24 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 521 | 0.040 |
Why?
|
| Chondrosarcoma | 1 | 2017 | 11 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 50 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 2016 | 14 | 0.030 |
Why?
|
| Reticulin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2016 | 26 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 125 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 571 | 0.030 |
Why?
|
| Sarcoma, Ewing | 1 | 2017 | 116 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2015 | 77 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 214 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 2015 | 129 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 165 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 670 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2017 | 267 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2015 | 93 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 296 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 888 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 19712 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2017 | 258 | 0.030 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2013 | 5 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2014 | 46 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2014 | 67 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1499 | 0.030 |
Why?
|
| Karyotyping | 1 | 2014 | 331 | 0.030 |
Why?
|
| Imines | 1 | 2013 | 9 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1751 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 160 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2542 | 0.030 |
Why?
|
| Tyrosine | 1 | 2013 | 152 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2013 | 131 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 4788 | 0.020 |
Why?
|
| Neprilysin | 1 | 2012 | 19 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 320 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3065 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2012 | 55 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 300 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 370 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 510 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 671 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 258 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 627 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2886 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 467 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 447 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 1069 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2771 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 300 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1297 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2826 | 0.020 |
Why?
|
| Pediatrics | 1 | 2017 | 1158 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 3100 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 3753 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 29498 | 0.010 |
Why?
|